Back to Journals » Patient Preference and Adherence » Volume 10

Patients’ perspectives and preferences in the choice of inhalers: the case for Respimat® or HandiHaler®

Authors Dekhuijzen PNR, Lavorini F, Usmani OS

Received 26 May 2016

Accepted for publication 7 July 2016

Published 18 August 2016 Volume 2016:10 Pages 1561—1572

DOI https://doi.org/10.2147/PPA.S82857

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Akshita Wason

Peer reviewer comments 2

Editor who approved publication: Dr Johnny Chen

Pieter Nicolaas Richard Dekhuijzen,1 Federico Lavorini,2 Omar S Usmani3

1Department of Pulmonary Diseases, Radboud University Medical Center, Nijmegen, the Netherlands; 2Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence, Italy; 3National Heart and Lung Institute, Imperial College London and Royal Brompton Hospital, London, UK


Abstract: Poor inhaler technique hampers the efficacy of drug therapy in asthma and chronic obstructive pulmonary disease. Not only does this affect individual patient care, but it also impacts on the wider health care economics associated with these conditions. Treatment guidelines recommend a systematic approach to drug class selection; however, standardization of inhaler selection is currently difficult owing to the complexity of the interaction between the inhaler device and the patient. Specifically, individual patient preference can influence how successful a treatment is overall. This article reviews inhaler devices from the patient perspective, with a particular focus on the dry powder inhaler HandiHaler® and Respimat® Soft Mist™ Inhaler. It discusses factors that influence device preference and treatment compliance and reviews tools that can aid health care professionals to better match inhaler devices to individual patients’ needs.

Keywords: asthma, chronic obstructive pulmonary disease, inhaler technique, Soft Mist™ Inhaler, tiotropium Respimat®, tiotropium HandiHaler®

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]